首页|期刊导航|中华医学杂志（英文版）|Antibody-drug conjugates in HER2-positive breast cancer

Antibody-drug conjugates in HER2-positive breast cancer

Lixi Li Di Zhang Binliang Liu Dan Lv Jingtong Zhai Xiuwen Guan Zongbi Yi Fei Ma

中华医学杂志（英文版）2022，Vol.135Issue(3)：261-267,7.

中华医学杂志（英文版）2022，Vol.135Issue(3)：261-267,7.DOI:10.1097/CM9.0000000000001932

Antibody-drug conjugates in HER2-positive breast cancer

Lixi Li ¹Di Zhang ¹Binliang Liu ¹Dan Lv ¹Jingtong Zhai ¹Xiuwen Guan ¹Zongbi Yi ¹Fei Ma¹

作者信息

1. Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
折叠

摘要

关键词

Antibody-drug conjugate/HER2-positive/Breast cancer/T-DM1/DS-8201

Key words

Antibody-drug conjugate/HER2-positive/Breast cancer/T-DM1/DS-8201

引用本文复制引用

Lixi Li,Di Zhang,Binliang Liu,Dan Lv,Jingtong Zhai,Xiuwen Guan,Zongbi Yi,Fei Ma..Antibody-drug conjugates in HER2-positive breast cancer[J].中华医学杂志（英文版）,2022,135(3):261-267,7.

基金项目

The study was supported by the grants from the National Natural Science Foundation of China (No.81874122) and the Chinese Academy of Medical Sciences (CAMS)Initiative for Innovative Medicine (No.2017-I2M-3-004). （No.81874122）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航